Multiple System Atrophy News and Research

RSS
Multiple-system atrophy (MSA) is a progressive neurological condition in which specific areas of the brain undergo neural degeneration. The three brain areas primarily affected are the brain stem, basal ganglia and cerebellum, portions of the brain that regulate bodily functions and motor control.
Discovery points toward a new strategy for treating Parkinson’s disease

Discovery points toward a new strategy for treating Parkinson’s disease

Nasal drugs show success in slowing Parkinson's disease progression in mice

Nasal drugs show success in slowing Parkinson's disease progression in mice

Brain diseases could have a greater societal impact than Covid-19, research finds

Brain diseases could have a greater societal impact than Covid-19, research finds

Gene therapy shows promise in children with devastating genetic disorder

Gene therapy shows promise in children with devastating genetic disorder

Researchers uncover the mysteries of sleep disorders in multiple system atrophy

Researchers uncover the mysteries of sleep disorders in multiple system atrophy

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

NIH awards $3.8 million to predict dementia in patients with Parkinson's disease

NIH awards $3.8 million to predict dementia in patients with Parkinson's disease

LRRK2 enzyme suppresses protein synthesis in Parkinson’s disease

LRRK2 enzyme suppresses protein synthesis in Parkinson’s disease

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

New technology distinguishes between two progressive neurodegenerative diseases

New technology distinguishes between two progressive neurodegenerative diseases

New recommendations aim to improve outcomes of Parkinson's disease patients

New recommendations aim to improve outcomes of Parkinson's disease patients

Penn researchers to develop critical tool for imaging the brains of patients with Parkinson's

Penn researchers to develop critical tool for imaging the brains of patients with Parkinson's

Newly discovered mechanism sheds light on how Parkinson’s disease can spread in the brain

Newly discovered mechanism sheds light on how Parkinson’s disease can spread in the brain

Study on REM sleep disorder patients provides key predictors of Parkinson's disease

Study on REM sleep disorder patients provides key predictors of Parkinson's disease

Study finds risk factors linked to REM sleep behavior disorder

Study finds risk factors linked to REM sleep behavior disorder

Experts in Parkinson's research propose roadmap for drug trials targeting alpha-synuclein

Experts in Parkinson's research propose roadmap for drug trials targeting alpha-synuclein

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

Study finds disease-causing mutation in French-Canadians

Study finds disease-causing mutation in French-Canadians

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.